Connect your AI

Lear Corporation LEA Other Restructuring Costs

Other Restructuring Costs at other companies

Charles River LaboratoriesCRL

$25.36M+64.4%

Mohawk IndustriesMHK

$7.7M-61.1%

Thermo Fisher ScientificTMO

$15M-84.7%

Campbell SoupCPB

$60M+140%

Edwards LifesciencesEW

$4.78M-68.7%

Crown HoldingsCCK

$0-100%

Other financials

Income statement

Revenue$5.8B+4.7%

Gross profit$450.3M+25.4%

Operating income$255.0M+40.4%

Net income$172.3M+114%

EPS (diluted)$3.34+124%

Balance sheet

Cash & equivalents$884.5M+13.0%

Total debt$3.5B+0.5%

Total equity$5.1B+9.2%

Total assets$15.5B+5.7%

Cash flow

Operating cash flow$98.1M+177%

CapEx$124.6M+19.8%

Free cash flow-$26.5M+88.6%

Valuation

Market cap$7B+29.8%

Enterprise value$9.64B+17.8%

P/E13.3×+2.0×

P/S0.3×+0.1×

Profitability

Gross margin6.8%-0.2pp

Operating margin3.7%—

Net margin2.2%+0.2pp

FCF margin3.1%+1.0pp

Returns & leverage

Return on equity10.8%+0.8pp

Debt / equity0.7×-0.1×

Current ratio1.3×0.0×

Where this comes from

Reported directly by Lear Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherRestructuringCosts.

The official record: Lear Corporation’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lear Corporation's other restructuring costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Lear Corporation's other restructuring costs?: Lear Corporation (LEA) reported other restructuring costs of $2.7M in Q1 2026.
How has Lear Corporation's other restructuring costs changed year-over-year?: Lear Corporation's other restructuring costs decreased by 32.5% year-over-year, from $4M to $2.7M.